NCT04381234View on ClinicalTrials.gov

Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 6, 2018

Primary Completion Date

March 10, 2019

Study Completion Date

May 5, 2020

Conditions
Hemodialysis Complication
Interventions
DEVICE

dialyzer

Asymmetric triacetate dialyzer

COMBINATION_PRODUCT

hemodialysis with citrate-containing dialysate

acetate-free dialysate

OTHER

predilution hemodiafiltration

predilution hemodiafiltration

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
collaborator

NIPRO

UNKNOWN

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04381234 - Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis | Biotech Hunter | Biotech Hunter